Purchase Order 36C24620P1340

Award Date 8/10/20
Potential Completion Date 8/9/25
Potential Value $382K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salisbury, NC 28144, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $4,166.40 contract is for an annual service agreement with a completion date of December 31, 2024. Roche Diagnostics is not a set-aside awardee for this contract. The contract is part of Roche's existing...
This $400,865.87 firm fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, which does not have a set-aside designation, is for cost per test services. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and other laboratory equipment and supplies to...
This federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, was made by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 8. The $100,838.70 firm fixed-price purchase order was awarded on May 1, 2016 with a completion date of January 12, 2018. Roche provides critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
This is a $92,104.71 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the renewal of a lab supply test requirement, with a period of performance through May 2020. Roche Diagnostics has been awarded multiple VA, Department of Defense, and other federal agency contracts to...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract has a ceiling value of $59,006.42 and a period of performance through March 31, 2025. The contract provides for the procurement of medical equipment and supplies, specifically clinical chemistry analyzers, reagents, and testing services. Roche...
This $297,244.05 firm fixed price delivery order contract was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract is for in vitro diagnostic reagents and supplies, and is not set-aside. Roche Diagnostics has previously held multiple General Services Administration (GSA) Schedule contracts and Indefinite...
This firm-fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 19, to Roche Diagnostics Corporation for the provision of Roche analyzers, reagents, supplies, and parts. The $213,723.53 contract has a period of performance through September 30, 2024 and does not have a set-aside designation. Roche Diagnostics is a major manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and related...
This is a $169,400.44 firm fixed-price purchase order contract awarded to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is with the Department of Veterans Affairs' Veterans Integrated Service Network 22 and does not have a set-aside designation. Through this award, Roche Diagnostics will provide reagents to support medical testing and laboratory operations at VA facilities. Roche Diagnostics has a history of providing...
This is a $130,466.74 firm fixed price delivery order awarded by the Veterans Integrated Service Network 19 (VISN 19) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for a Blood Gas Maintenance and Rental Agreement, which provides critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $394,430.35 contract is for the delivery of Roche Ventana reagents to support operations at VA medical facilities. This purchase order was not set aside for a specific business type. Roche Diagnostics has a long history of providing critical care medical equipment, supplies, and services to...

This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $381,748.64 contract provides a preventive service agreement to maintain and support critical care analyzers, reagents, test kits, and associated laboratory products and services supplied by Roche to VA hospitals. This award is part of Roche's existing Federal Supply Schedule (FSS) contract with the VA, which allows the agency to acquire essential medical devices and consumables on an as-needed basis through established pricing and terms. The contract does not have a set-aside designation and runs through August 2025.

Generated 7/19/24, 9:42 AM